Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Male Breast Cancer
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Breast Cancer (2007
)
HER2 Negative Breast Cancer (415
)
HER2 Positive Breast Cancer (403
)
Hormone Receptor Positive Breast Cancer (308
)
Triple Negative Breast Cancer (299
)
Estrogen Receptor Positive Breast Cancer (204
)
Hormone Receptor Negative Breast Cancer (3
)
Breast Cancer (2007
)
HER2 Negative Breast Cancer (415
)
HER2 Positive Breast Cancer (403
)
Hormone Receptor Positive Breast Cancer (308
)
Triple Negative Breast Cancer (299
)
Estrogen Receptor Positive Breast Cancer (204
)
Hormone Receptor Negative Breast Cancer (3
)
›
Associations
(9)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
HR positive + HER-2 negative
Male Breast Cancer
HR positive + HER-2 negative
Male Breast Cancer
tamoxifen
Sensitive: A2 - Guideline
tamoxifen
Sensitive
:
A2
tamoxifen
Sensitive: A2 - Guideline
tamoxifen
Sensitive
:
A2
No biomarker
Male Breast Cancer
No biomarker
Male Breast Cancer
HER2 inhibitor
Sensitive: A2 - Guideline
HER2 inhibitor
Sensitive
:
A2
HER2 inhibitor
Sensitive: A2 - Guideline
HER2 inhibitor
Sensitive
:
A2
HR positive + HER-2 negative
Male Breast Cancer
HR positive + HER-2 negative
Male Breast Cancer
fulvestrant
Sensitive: A2 - Guideline
fulvestrant
Sensitive
:
A2
fulvestrant
Sensitive: A2 - Guideline
fulvestrant
Sensitive
:
A2
HR positive
Male Breast Cancer
HR positive
Male Breast Cancer
Aromatase inhibitor
Sensitive: A2 - Guideline
Aromatase inhibitor
Sensitive
:
A2
Aromatase inhibitor
Sensitive: A2 - Guideline
Aromatase inhibitor
Sensitive
:
A2
HR positive
Male Breast Cancer
HR positive
Male Breast Cancer
tamoxifen
Sensitive: A2 - Guideline
tamoxifen
Sensitive
:
A2
tamoxifen
Sensitive: A2 - Guideline
tamoxifen
Sensitive
:
A2
ER positive
Male Breast Cancer
ER positive
Male Breast Cancer
tamoxifen
Sensitive: A2 - Guideline
tamoxifen
Sensitive
:
A2
tamoxifen
Sensitive: A2 - Guideline
tamoxifen
Sensitive
:
A2
PIK3CA mutation + HR positive + HER-2 negative
Male Breast Cancer
PIK3CA mutation + HR positive + HER-2 negative
Male Breast Cancer
alpelisib
Sensitive: A2 - Guideline
alpelisib
Sensitive
:
A2
alpelisib
Sensitive: A2 - Guideline
alpelisib
Sensitive
:
A2
HR positive + HER-2 negative
Male Breast Cancer
HR positive + HER-2 negative
Male Breast Cancer
ribociclib
Sensitive: B - Late Trials
ribociclib
Sensitive
:
B
ribociclib
Sensitive: B - Late Trials
ribociclib
Sensitive
:
B
HR positive + HER-2 negative
Male Breast Cancer
HR positive + HER-2 negative
Male Breast Cancer
palbociclib
Sensitive: C3 – Early Trials
palbociclib
Sensitive
:
C3
palbociclib
Sensitive: C3 – Early Trials
palbociclib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login